Share
Johnson & Johnson to Host Fourth-Quarter/Full-Year 2013 Earnings Meeting
Johnson & Johnson to Host Fourth-Quarter/Full-Year 2013 Earnings Meeting
Share

New Brunswick, NJ (Dec. 18, 2013) - Johnson & Johnson (NYSE: JNJ) will host an analyst meeting at 8:30 a.m. (Eastern Time) on Tuesday, Jan. 21, to discuss fourth-quarter and full-year 2013 financial results.  Alex Gorsky, Chairman of the Board of Directors and Chief Executive Officer; Dominic J. Caruso, Vice President, Finance and Chief Financial Officer; and Louise Mehrotra, Vice President, Investor Relations will host the meeting.

Investors and other interested parties may also access the meeting in the following ways:

  • The meeting will also be webcast and available through www.investor.jnj.com.  The webcast is optimized for mobile streaming on iOS devices such as iPhones®, iPods®, and iPads®.  A webcast and podcast replay will be available approximately two hours after the meeting concludes through www.investor.jnj.com.
     
  • Users of the Johnson & Johnson Investor Relations mobile app for the iPad® and iPhone® can also access the event. This free app is available in the iTunes® store and includes stock information, news releases, Company information, webcasts, SEC filings, the Company’s pharmaceutical product pipeline and Annual Reports, among other information.

About Johnson & Johnson
Caring for the world, one person at a time inspires and unites the people of Johnson & Johnson. We embrace research and science - bringing innovative ideas, products and services to advance the health and well-being of people. Our approximately 128,700 employees at more than 275 Johnson & Johnson operating companies work with partners in health care to touch the lives of over a billion people every day, throughout the world.

###

Press Contacts:
Ernie Knewitz
(732) 524-6623
(917) 697-2318 (M)

Investor Contacts:
Louise Mehrotra
(732) 524-6491
Lisa Romanko
(732) 524-2034

This site uses cookies as described in our Cookie Policy. Please click the "Accept" button or continue to use our site if you agree to our use of cookies.
You are now leaving jnj.com. The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.
Continue